Cargando…
Thymic Self-Antigen Expression for the Design of a Negative/Tolerogenic Self-Vaccine against Type 1 Diabetes
Before being able to react against infectious non-self-antigens, the immune system has to be educated in the recognition and tolerance of neuroendocrine proteins, and this critical process essentially takes place in the thymus. The development of the autoimmune diabetogenic response results from a t...
Autores principales: | Chentoufi, Aziz Alami, Geenen, Vincent |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102425/ https://www.ncbi.nlm.nih.gov/pubmed/21647405 http://dx.doi.org/10.1155/2011/349368 |
Ejemplares similares
-
Type I Diabetes-Associated Tolerogenic Properties of Interleukin-2
por: Chentoufi, Aziz Alami, et al.
Publicado: (2011) -
Type 1 Diabetes Immunological Tolerance and Immunotherapy
por: Chentoufi, Aziz Alami, et al.
Publicado: (2011) -
Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
por: Pfeil, Jennifer, et al.
Publicado: (2021) -
Thymic self-antigen expression for immune tolerance and surveillance
por: Benlaribi, Rayene, et al.
Publicado: (2022) -
Towards a Rational Design of an Asymptomatic Clinical Herpes Vaccine: The Old, the New, and the Unknown
por: Alami Chentoufi, Aziz, et al.
Publicado: (2012)